Heart, Vascular & Thoracic Institute (Miller Family) Outcomes
Valve Disease
Transcatheter Aortic Valve Replacement
Transcatheter Aortic Valve Replacement: Volume and In-Hospital Mortality
2020 – 2023
Since the start of the transcatheter aortic valve replacement (TAVR) program in 2006, Cleveland Clinic consistently achieves better-than-expected outcomes.
The in-hospital mortality rates for patients who had TAVR at Cleveland Clinic's Main Campus, Hillcrest Hospital and Fairview Hospital remain lower than the expected rate. Calculated observed to expected ratios remain less than the value of 1 indicating that Cleveland Clinic mortality is better than expected for these procedures.
| Year | O:E (observed to expected mortality ratio) |
|---|---|
| 2020 | 0.1 |
| 2021 | 0.6 |
| 2022 | 0.7 |
| 2023 | 0.2 |
Source: Data from the Vizient Clinical Data Base used with permission of Vizient, Inc. All rights reserved.
Source for mortality rates and volume: Society of Thoracic Surgeons (STS) National Adult Cardiac Surgery Data Base
Transcatheter Aortic Valve Replacement: Volume by Approach
2023, N = 699
The majority of transcatheter aortic valve replacement (TAVR) procedures done at Cleveland Clinic involve a transfemoral approach. This approach was used in 97.7% of the 699 TAVR procedures performed in 2023.
Source: Society of Thoracic Surgeons (STS) National Adult Cardiac Surgery Data Base
The total TAVR procedures reported were done by a team of cardiothoracic surgeons and interventional cardiologists.
